Sanofi reported multiple developments including their partnership with Biovac for polio vaccine production in Africa (June 20, 2024), advancements in hemophilia treatments (June 21, 2024), and the appointment of Audrey Duval Derveloy as Global Head of Corporate Affairs (June 21, 2024). They also shared positive outcomes from a Dupixent trial for children (June 26, 2024).